Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1177 - 1184 of 11439 results
Energy & Sustainability Litigation Updates — March 2023
March 23, 2023| Article| Viewpoint
Massachusetts to End Public Health Emergency
March 23, 2023| Blog| Viewpoint
Mintz Opens Toronto Office With Addition Of Five Lead Attorneys
March 23, 2023| News
Energy & Sustainability Client Feature — Boston Metal
March 23, 2023| Article| Viewpoint
Energy & Sustainability M&A Activity — March 2023
March 23, 2023| Article| Viewpoint
Setting the Pace — 2023 Mintz Women's Report
March 22, 2023| Resources| Viewpoint
Setting the Pace — Women-Led Practices
March 22, 2023| Resources| Viewpoint
Setting the Pace — Client Testimonials
March 22, 2023| Resources| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.